GlaxoSmithKline Finds ‘Synta’ergy With $1 Billion Deal For Oncology Candidate
Synta CEO tells “The Pink Sheet” DAILY deal will allow firm to move other pipeline candidates through development on its own.
Synta CEO tells “The Pink Sheet” DAILY deal will allow firm to move other pipeline candidates through development on its own.